As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: May 10, 2012
Type 2 diabetes and poor blood sugar may accelerate loss of brain size and function
by Travis Hill for RX Daily
As you grow old, your brain starts to get smaller and lose power. Certain diseases can make this decline in brain function even worse. It seems diabetes may be one of these diseases.
Pre-diabetes and type 2 diabetes may speed up the decline in brain size and mental function associated with aging.
It is normal to lose brain volume as you age. However, elderly people with high blood sugar – such as those with diabetes and pre-diabetes – appear to lose more brain volume than those without diabetes over a two year period, according to a recent study led by Katherine Samaras, Ph.D., of the Garvan Institute of Medical Research, and colleagues.
The frontal lobe is a part of the brain associated with decision-making, long-term memory, and emotional control. When the frontal lobe gets smaller, it can have a heavy effect on a person’s mental function and quality of life.
Dr. Samaras and colleagues found that people with out-of-control blood sugar levels lost nearly two and a half times more brain volume than those with stable blood sugar levels. They concluded that a person’s blood sugar after two years can act as a strong predictor of a loss in brain size. “These findings highlight the importance of prevention of diabetes,” says Dr. Samaras.
“They also emphasize that, in the elderly, clinicians and allied health professionals need to understand that the complexity of diabetes care needs to accommodate expected declines in cognitive function.”
While the study found a relationship between blood sugar levels and brain size, it does not explain how diabetes causes the loss in brain size and function. More research is needed to understand the role of diabetes in declining brain function.
“We need to understand why these changes in cognition and brain size occur,” explains Dr. Samaras.
“Is it due merely to higher blood sugars? Is the brain subject to the toxic effects of glucose, just as peripheral nerves are? Tow what extent do other factors associated with diabetes also contribute to the decline in brain size and function, for example inflammation or blood fat levels,” she asks.
“We also need to learn how we can prevent or deter the negative effects of diabetes on the brain,” she adds.
For their study, the researchers looked at MRI scans of 312 Australians between 70 and 90 years old. None of the participants had dementia (loss of brain function) at the beginning of the study.
The participants were separated into four groups. The first group had normal, stable blood sugar levels. The second had stable pre-diabetes (higher than normal blood sugar levels, but not quite high enough to be called diabetes. The third had blood sugar levels that had gotten worse. The fourth group consisted of those who already had type 2 diabetes.
While the normal group lost an average of 18.4 cubic centimeters of brain volume over two years, those with stable pre-diabetes lost an average of 26.6 cubic centimeters – about 1.4 times more brain volume loss than those in the normal group. Both those with worsening blood sugar and those with diabetes lost 2.3 times more brain volume than those with normal blood sugar.
This research was presented at the joint International Congress of Endocrinology and European Congress of Endocrinology in Florence, Italy. As such, the study still needs to be reviewed by a body of peers.
Nearly 26 million individuals are affected by diabetes in the United States each year, with about seven million people going undiagnosed. Diabetes is a chronic metabolic disease with no cure in which a person has high blood sugar because the body does not produce enough insulin (Type 1) or because cells do not respond to the insulin that is produced (Type 2).
There are three main types of diabetes: Type 1, Type 2 and Gestational. Several groups of oral drugs, are effective for Type 2, such as Glucophage, Glucotrol, and Prandin, among many others. The therapeutic combination in Type 2 may eventually include injected insulin as symptoms worsen.
Yale researchers have tested a new method for directly measuring synaptic loss in individuals with Alzheimer’s disease. The method, which uses PET imaging technology to scan for a specific protein in the brain linked to synapses, has...
Sometimes, the hardest part of living with a mental illness isn’t the symptoms, or the management — it’s dealing with stigma from other people. And unfortunately, many people who live with mental illness face stigma...
The root cause of behavioural outbursts in someone with Alzheimer’s disease is mostly due to the decline in the person’s language and communication skills. Outbursts also can be caused by an unmet need or needs. The affected...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.